Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 1: Surveillance Note 1)FREE

Disclosures: All financial and intellectual disclosures of interest were declared, and potential conflicts were discussed and managed. Dr. Crandall was recused from authorship and voting due to moderate-level conflicts (recently authored relevant publications). A record of disclosures of interest and management of conflicts is kept for each Clinical Guidelines Committee meeting and conference call and can be viewed at www.acponline.org/clinical_information/guidelines/guidelines/conflicts_cgc.htm. Disclosure forms are available with the article online.

This article was published at Annals.org on 4 February 2025.

This article, authored by Amir Qaseem, MD, PhD, MHA; Thomas G. Cooney, MD; Tatyana A. Shamliyan, MD, MS; Jennifer Yost, PhD, RN; and Lauri A. Hicks, DO was developed for the Clinical Guidelines Committee of the American College of Physicians. Members of the Clinical Guidelines Committee who served as authors were Lauri A. Hicks, DO (Vice Chair); Ethan M. Balk, MD, MPH; Thomas G. Cooney, MD; J. Thomas Cross, Jr., MD, MPH; Nick Fitterman, MD; Johanna Lewis, PhD (nonphysician public member); Amy M. Linsky, MD, MSc; Michael Maroto, JD, MBA (nonphysician public member); Matthew C. Miller, MD; Adam J. Obley, MD; Douglas K. Owens, MD, MS; Paul G. Shekelle, MD, PhD, MPH; and Jeffrey A. Tice, MD. Authors from ACP were Itziar Etxeandia-Ikobaltzeta, PharmD, PhD; Amir Qaseem, MD, PhD, MHA; Tatyana A. Shamliyan, MD, MS; and Jennifer Yost, PhD, RN. Approved by the ACP Board of Regents on 18 November 2024.